IL162133A0 - Method of increasing protein expression, proteins and polynucleotides - Google Patents

Method of increasing protein expression, proteins and polynucleotides

Info

Publication number
IL162133A0
IL162133A0 IL16213302A IL16213302A IL162133A0 IL 162133 A0 IL162133 A0 IL 162133A0 IL 16213302 A IL16213302 A IL 16213302A IL 16213302 A IL16213302 A IL 16213302A IL 162133 A0 IL162133 A0 IL 162133A0
Authority
IL
Israel
Prior art keywords
amino acid
polynucleotides
proline
protein expression
proteins
Prior art date
Application number
IL16213302A
Other languages
English (en)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of IL162133A0 publication Critical patent/IL162133A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/144—Tumor necrosis factor

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL16213302A 2001-11-30 2002-11-21 Method of increasing protein expression, proteins and polynucleotides IL162133A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34064801P 2001-11-30 2001-11-30
PCT/EP2002/013059 WO2003046160A2 (fr) 2001-11-30 2002-11-21 Procedes pour augmenter les niveaux d'expression de proteines

Publications (1)

Publication Number Publication Date
IL162133A0 true IL162133A0 (en) 2005-11-20

Family

ID=23334343

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16213302A IL162133A0 (en) 2001-11-30 2002-11-21 Method of increasing protein expression, proteins and polynucleotides

Country Status (12)

Country Link
US (2) US7258997B2 (fr)
EP (1) EP1448772B1 (fr)
JP (1) JP2005535281A (fr)
AT (1) ATE367438T1 (fr)
AU (1) AU2002338947B2 (fr)
CA (1) CA2466298A1 (fr)
DE (1) DE60221273D1 (fr)
DK (1) DK1448772T3 (fr)
ES (1) ES2290337T3 (fr)
IL (1) IL162133A0 (fr)
PT (1) PT1448772E (fr)
WO (1) WO2003046160A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1448772T3 (da) * 2001-11-30 2007-11-19 Serono Lab Fremgangsmåder til forögelse af ekspressionsniveauer af human TNF-receptor
JP2008504009A (ja) * 2003-12-23 2008-02-14 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ 腫瘍壊死因子結合蛋白質を生産する方法
US8722348B2 (en) 2008-05-28 2014-05-13 Wayne State University Method and composition for a protein transduction technology and its applications
EP3777538B1 (fr) 2011-05-02 2023-06-28 Wayne State University Technique d'utilisation de cellules souches pluripotentes induites par les protéines
CN106170295B (zh) 2013-10-25 2020-11-06 韦恩州立大学 与通过蛋白诱导的体内细胞重编程的细胞转化相关的方法、系统和组合物
EP3987028A4 (fr) * 2019-06-21 2023-07-19 Kernal Biologics, Inc. Expression de protéine oncosélective modifiée

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0393438B1 (fr) * 1989-04-21 2005-02-16 Amgen Inc. Récepteur du TNF, protéine liant le TNF at ADN codant pour ceux-ci
EP0614353A1 (fr) * 1991-11-25 1994-09-14 Richardson-Vicks, Inc. Composition anti-rides et/ou pour la lutte contre l'atrophie de la peau
IL107268A0 (en) * 1993-10-12 1994-01-25 Yeda Res & Dev Molecules influencing the shedding of the tnf receptor, their preparation and their use
EP1390497A2 (fr) * 2001-05-25 2004-02-25 Genset Adnc et proteines humaines, ainsi que leurs utilisations
DK1448772T3 (da) * 2001-11-30 2007-11-19 Serono Lab Fremgangsmåder til forögelse af ekspressionsniveauer af human TNF-receptor

Also Published As

Publication number Publication date
DK1448772T3 (da) 2007-11-19
US7258997B2 (en) 2007-08-21
PT1448772E (pt) 2007-10-02
WO2003046160A3 (fr) 2003-07-31
ES2290337T3 (es) 2008-02-16
CA2466298A1 (fr) 2003-06-05
AU2002338947B2 (en) 2007-09-13
US20050074840A1 (en) 2005-04-07
EP1448772A2 (fr) 2004-08-25
US20080014635A1 (en) 2008-01-17
JP2005535281A (ja) 2005-11-24
EP1448772B1 (fr) 2007-07-18
DE60221273D1 (de) 2007-08-30
AU2002338947A1 (en) 2003-06-10
WO2003046160A2 (fr) 2003-06-05
ATE367438T1 (de) 2007-08-15

Similar Documents

Publication Publication Date Title
WO2002002627A3 (fr) Proteine zcyto21de type interferon
EA199900939A1 (ru) Остеопротегерин-связывающие белки и рецепторы
EP1373301A4 (fr) Diminution de l'antigenicite de proteines de fusion
IL184112A0 (en) A method for producing polypeptides or proteins in a disulfide-bridged two-chain form
UA97628C2 (ru) Способ получения fc-фрагмента иммуноглобулина, свободного от начального метионинового остатка, в массовом масштабе
WO2002060951A3 (fr) Methodes et compositions permettant de reduire la clairance du facteur viii, mediee par l'heparan-sulfate proteoglycane
DE60323210D1 (en) Eukaryontische signalsequenzen für polypeptid-expr
WO2000071714A3 (fr) Procedes de reduction de la clairance du facteur viii et compositions correspondantes
DE60335726D1 (de) Chromoprotein und fluoroproteine
DE69827262D1 (de) Penaeidine: antimikrobielle peptide aus krebstieren
DK1098972T3 (da) Protein med lighed med neuroendokrinspecifikt protein samt cDNA kodende derfor
PE20020857A1 (es) Proteinas de fusion cuya parte del n-terminal es un derivado de hirudina para la produccion de proteinas recombinantes a traves de la secresion por levaduras
IL162133A0 (en) Method of increasing protein expression, proteins and polynucleotides
EP1156103A3 (fr) Oplophorus luciferase
IL162780A (en) A method for producing a protected peptide fragment
NO971508L (no) Analoger av sur fibroblastvekstfaktor med forökt stabilitet og biologisk aktivitet
WO2000058465A3 (fr) Analogues polypeptidiques de flint
EA200400392A1 (ru) Связывающий каспазу-8 белок, его получение и применение
AU2676399A (en) Novel cystine knot protein and materials and methods for making it
WO2000000506A3 (fr) Proteines humaines possedant des domaines hydrophobes et adn codant ces proteines
JP2005535281A5 (fr)
EP0750040A3 (fr) Variants de la protéine stimulatrice des macrophages et procédés de fabrication
NO992531L (no) Fremgangsmåter ved fremstilling av rekombinant protein
EP1627063A4 (fr) Induction de la floraison
WO2003072733A3 (fr) Enzyme bace modifiee